BOSTON, Dec. 19, 2019 /PRNewswire/ -- Haemonetics Corporation HAE announced that the Company intends to publish third quarter fiscal year 2020 financial results at 6:00 am EDT on Tuesday, February 4, 2020. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on February 4, 2020.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1906607
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/fuq43ous
Webcast replay will be available from February 4, 2020 after 11:00 am EDT.
ABOUT HAEMONETICS
Haemonetics HAE is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact: | Media Contact: |
Olga Guyette, Director-Investor Relations | Carla Burigatto, VP-Global Communications |
(781) 356-9763 | (781) 348-7263 |
SOURCE Haemonetics Corporation
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.